Event Date

Breast Cancer Trials’ next online Q and A session will have a panel of experts discussing and taking questions on Triple Negative Breast Cancer. Click here to register and submit a question. Triple negative breast cancer accounts for approximately 15% of all breast cancers; it lacks the usual receptors found on breast cancer cells; it is more common in younger women and in those with a BRCA gene mutation; and it is often a more aggressive type of cancer.